ConductScience.org, home

Paper42903311PubMed

Butyrate-associated antiproliferative and antitumor effects of Eubacterium limosum KGMB01548 in colorectal cancer.

Yu SY and 8 others. Front Microbiol, 2026.

Cite this record

ConductScience Library. Butyrate-associated antiproliferative and antitumor effects of Eubacterium limosum KGMB01548 in colorectal cancer. Papers, record 42903311. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42903311

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Butyrate-associated antiproliferative and antitumor effects of Eubacterium limosum KGMB01548 in colorectal cancer.
Journal
Front Microbiol
Year
2026
Publication types
Journal Article
Revised in PubMed
2026-10-23

Source PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Yu SYSeung Yeob
2Bak JEJeong Eun
3Oh BSByeong Seob
4Ryu SWSeoung Woo
5Park HHyebin
6Yu DJDong Jin
7Lee JJiyoung
8Kim JSJi-Sun
9Lee JHJu Huck

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References78

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
124388214The role of short-chain fatty acids in health and disease.Adv Immunol2014https://conductscience.org/library/papers/24388214PubMed
225956767Energy Conservation Model Based on Genomic and Experimental Analyses of a Carbon Monoxide-Utilizing, Butyrate-Forming Acetogen, Eubacterium limosum KIST612.Appl Environ Microbiol2015https://conductscience.org/library/papers/25956767PubMed
333652061Gut microbes and health.Gastroenterol Hepatol2021https://conductscience.org/library/papers/33652061PubMed
420383131QIIME allows analysis of high-throughput community sequencing data.Nat Methods2010https://conductscience.org/library/papers/20383131PubMed
532457487Revisiting the role of CD4+ T cells in cancer immunotherapy-new insights into old paradigms.Cancer Gene Ther2021https://conductscience.org/library/papers/32457487PubMed
636189423Functional high-throughput screen identifies microRNAs that promote butyrate-induced death in colorectal cancer cells.Mol Ther Nucleic Acids2022https://conductscience.org/library/papers/36189423PubMed
735736458An Improved Method to Quantify Short-Chain Fatty Acids in Biological Samples Using Gas Chromatography-Mass Spectrometry.Metabolites2022https://conductscience.org/library/papers/35736458PubMed
836564565Tumour-infiltrating lymphocytes: from prognosis to treatment selection.Br J Cancer2023https://conductscience.org/library/papers/36564565PubMed
933549042Inhibitory effect of sodium butyrate on colorectal cancer cells and construction of the related molecular network.BMC Cancer2021https://conductscience.org/library/papers/33549042PubMed
1026210164Proteobacteria: microbial signature of dysbiosis in gut microbiota.Trends Biotechnol2015https://conductscience.org/library/papers/26210164PubMed
1136440358Next-Generation Probiotics: Microflora Intervention to Human Diseases.Biomed Res Int2022https://conductscience.org/library/papers/36440358PubMed
1232433595Interaction between microbiota and immunity in health and disease.Cell Res2020https://conductscience.org/library/papers/32433595PubMed
1334867852Cell-Free Supernatant of Odoribacter splanchnicus Isolated From Human Feces Exhibits Anti-colorectal Cancer Activity.Front Microbiol2021https://conductscience.org/library/papers/34867852PubMed
1436448791Gut Microbiota Eubacterium callanderi Exerts Anti-Colorectal Cancer Activity.Microbiol Spectr2022https://conductscience.org/library/papers/36448791PubMed
1530214578Butyrate upregulates the TLR4 expression and the phosphorylation of MAPKs and NK-κB in colon cancer cell in vitro.Oncol Lett2018https://conductscience.org/library/papers/30214578PubMed
1631281534Integrated microbiome and metabolome analysis reveals a novel interplay between commensal bacteria and metabolites in colorectal cancer.Theranostics2019https://conductscience.org/library/papers/31281534PubMed
1734210970Microbial short-chain fatty acids modulate CD8+ T cell responses and improve adoptive immunotherapy for cancer.Nat Commun2021https://conductscience.org/library/papers/34210970PubMed
1840568973Eubacterium limosum modulates tumor microenvironments and produces antitumor metabolites active against colorectal cancer.ISME J2025https://conductscience.org/library/papers/40568973PubMed
1925392425Rfam 12.0: updates to the RNA families database.Nucleic Acids Res2015https://conductscience.org/library/papers/25392425PubMed
2034895176Gut microbiome and its role in colorectal cancer.BMC Cancer2021https://conductscience.org/library/papers/34895176PubMed

See all 78 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42903311

GET https://conductscience.org/api/papers/v1/42903311/references?page=2